Jeff Bolle was a larger than life figure roaming the sidelines of Marquette University High School football games. A standout ...

European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for ...

Nearly a year after receiving a life-saving liver transplant, a Young County girl and her family are feeling very thankful.

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its ...

A walk-a-thon fundraiser steps off in New Bedford this weekend in support of "Saige the Brave" following the 1-year-old's ...

The global market for primary sclerosing cholangitis (PSC) is on an impressive growth trajectory, with forecasts estimating a ...

Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

While the FDA will take into consideration the committee’s vote, the vote is not binding upon the agency. The FDA will make the final decision and has assigned a Prescription Drug User Fee Act (PDUFA) ...

Independent advisers to the U.S. Food and Drug Administration said on Friday that the available data from Intercept's liver ...

Intercept's oral drug, Ocaliva, had been approved under the accelerated approval pathway to treat patients with primary ...

Obeticholic acid was given accelerated approval by the FDA in May 2016 as a second-line treatment for PBC patients not ...